{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-062424","form_type":"8-K","ticker":"VREOF","cik":"0001771706","company_name":"Vireo Growth Inc.","filed_at":"2023-05-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.488410+00:00","generated_at":"2026-06-14T19:57:44.270458+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Goodness Growth Holdings Q1 revenue $19.1M (+22% YoY); positive operating income of $0.4M","bullets":["Q1 revenue $19.1M (+22.1% YoY); gross margin 49.9% vs 15.9%; SG&A down 22.6%.","Operating income of $0.4M vs loss of $7.8M in prior year; EBITDA $1.4M.","Closed $2M initial tranche of $10M convertible debt; 12% interest; conversion at $0.145; warrants for 6.25M shares.","Credit facility amendment extends maturity to Apr 2024, removes amortization; up to 15M shares to lenders.","Management reorganization: Josh Rosen interim CEO, Amber Shimpa as CEO of Vireo Health MN, founder becomes Exec Chairman."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-062424","json":"https://secwatch.observer/filing/0001104659-23-062424.json","markdown":"https://secwatch.observer/filing/0001104659-23-062424.md","text":"https://secwatch.observer/filing/0001104659-23-062424.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1771706/000110465923062424/0001104659-23-062424-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1771706/000110465923062424/tm2316190d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T19:57:44.270458+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9ea55a9ecd0d0d82561f33d099f6dd143150e118","claim":"Vireo Growth Inc. reported first quarter ended March 31, 2023 results: revenue $ 19.1.","evidence_excerpt":"referenced in this press are denominated in U.S. dollars. Summary of Key Financial Metrics Three Months Ended US $ in millions March 31, 2023 2022 Variance GAAP Revenue $ 19.1 $ 15.6 22.1 % Revenue (excluding discontinued operations) $ 19.1 $ 14.6 30.5 % GAAP Gross Profit $ 9.5 $ 2.5 280.0 % Gross Profit Margin 49.9 % 15.9 % 3,400 bps SG&A Expenses","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1771706/000110465923062424/0001104659-23-062424-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2023"},{"label":"Revenue","value":"$ 19.1"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}